Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricMRNAModernaBIIBBiogenONCBeOne Medicines AG
Snapshot
Price$57.77$205.63$346.25
Market cap$31.65B$31.91B$33.43B
Valuation
P/E—22.1x71.9x
Forward P/E—24x—
Growth
Revenue growth-30.0%1.2%36.2%
EPS growth—-8.1%—
Profitability
Net margin-143.6%13.8%7.8%
ROE-36.7%7.5%5.2%
Balance sheet & cash
Debt / equity0.07x0.34x0.25x
Free cash flow yield-13.6%6.8%—
Dividend yield———
Verdict
Investment ratingWeak· 17Neutral· 49Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearMRNAtoday $58BIIBtoday $206ONCtoday $346
2027$44.19 – $64.82+12% CAGR$157.31 – $230.72+12% CAGR$353.64 – $518.68+50% CAGR
2028$45.08 – $66.11+7% CAGR$160.45 – $235.33+7% CAGR$481.59 – $706.33+43% CAGR
2029$45.98 – $67.44+5% CAGR$163.66 – $240.04+5% CAGR$655.83 – $961.88+41% CAGR
2030$46.90 – $68.79+4% CAGR$166.94 – $244.84+4% CAGR$893.11 – $1,309.89+39% CAGR
2031$47.84 – $70.16+4% CAGR$170.27 – $249.74+4% CAGR$1,216.24 – $1,783.81+39% CAGR
5-yr CAGR-3.7% – 4.0%-3.7% – 4.0%28.6% – 38.8%